Insmed (INSM) reported a quarterly loss of $0.52 per share, outperforming the Zacks Consensus loss of $0.69. The loss also narrowed from $1.70 per share a year ago, suggesting improving profitability despite remaining unprofitable.
Insmed (INSM) reported a quarterly loss of $0.52 per share, outperforming the Zacks Consensus loss of $0.69. The loss also narrowed from $1.70 per share a year ago, suggesting improving profitability despite remaining unprofitable.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
